Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leaching is a physicochemical process rather than a specific biological target molecule, receptor, or enzyme. In the biotechnology and pharmaceutical industries, it refers to the unintended migration of chemical or biological substances from manufacturing equipment, container-closure systems, or medical devices into a drug product under normal storage and use conditions [3, 4, 6]. Common examples include the leaching of Protein A from affinity chromatography resins during purification or the release of plasticizers (e.g., phthalates), antioxidants, and metal ions from plastic packaging into liquid formulations [1, 2, 5]. While leaching is not a therapeutic target, it is a significant concern for drug safety and efficacy, as 'leachables' can be toxic, carcinogenic, or immunogenic, and may also cause degradation of the active pharmaceutical ingredient [9, 10]. Consequently, characterizing and controlling extractables and leachables (E&L) is a critical regulatory requirement in drug development and manufacturing [6, 10]. Proper management of leaching ensures that any substances entering the drug product remain below established safety thresholds to prevent adverse patient reactions [10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leaching.